Pathologic spectrum and prognostic significance of underlying liver disease in hepatocellular carcinoma

Surgical Oncology Clinics of North America

Volumn 12, Issue 1, 2003, Pages 13-24

  Mino, Mari ^a,b   Lauwers, Gregory Y ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSEL; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; HEPATITIS; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LYMPH; MITOSIS; PATHOLOGY; PROGNOSIS; REVIEW; TUMOR GROWTH; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 0037271229     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(02)00087-X     Document Type: Review

References (60)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
2. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
3. Bilimoria MM, Lauwers GY, Doherty DA, et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001;136:528-35.
4. Kobayashi S, Hayashi H, Itoh Y, et al. Detection of minus-strand hepatitis C virus RNA in tumor tissues of hepatocellular carcinoma. Cancer 1994;73:48-52.
5. Okuda K, Toshiro N, Sakamoto K, et al. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers. Cancer 1982;49:450-5.
6. Bralet M-P, Regimbeau J-M, Pineau P, et al. Hepatocellular carcinoma occuring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000;32:200-4.
7. Grando-Lemaire V, Guettier C, Chevret S, et al. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999;31:508-13.
8. Toyosaka A, Okamoto E, Mitsunobu M, et al. Pathologic and radiographic studies of intrahepatic metastasis in hepatocellular carcinoma: the role of efferent vessels. HPB Surg 1996;10:97-104.
9. Liver Cancer Study Group of Japan. Classification of primary liver cancer. Tokyo: Kanehara; 1997.
10. Hui AM, Takayama T, Sano K, et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol 2000;33:975-9.
11. Yuki K, Hirohashi S, Sakamoto M, et al. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990;66:2174-9.
12. Trevisani F, Caraceni P, Bernardi M, et al. Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 1993;72:1557-63.
13. Kanai T, Hirohashi S, Upton MP, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987;60:810-9.
14. Lai ECS, You KT, Ng OL, Shek TW. The pathological basis of resection margin for hepatocellular carcinoma. World J Surg 1993;17:786-91.
15. Nagao T, Inoue S, Goto S, et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987;205:33-40.
16. Nagao T, Inoue S, Yoshimi F, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990;211:28-33.
17. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995;19:35-41.
18. Sakamoto M, Hirohashi S, Tsuda H, et al. Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am J Surg Pathol 1989;13:1064-7.
19. Arii S, Tanaka J, Yamazoe Y, et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992:69:913-9.
20. Vauthey JN, Lauwers GY, Esnaola NF, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002;20:1527-36.
21. Lauwers G, Balis U, Regimbeau J-M, et al. Prognostic histologic Indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol 2002;26:25-34.
22. Kishi K, Shikata T, Hirohashi S, et al. Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases. Cancer 1983;51:542-8.
23. Le Treut YP, Pons J, Hardwigsen J, et al. Hepatocellular carcinoma in a non-cirrhotic liver. Presentation of series of 77 operated patients [in French]. Chirurgie 1999;124:485-93.
24. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 1996;105:65-75.
25. Smalley SR, Moertel CG, Hilton JF, et al. Hepatoma in the noncirrhotic liver. Cancer 1988;62:1414-24.
26. Edmonson H, Steiner P. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
27. Haratake J, Takeda S, Kasai T, et al. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma. Cancer 1993;72:1178-83.
28. Wayne JD, Lauwers GY, Ikai I, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002;235:1-10.
29. Nakashima T, Kojiro M. Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 1986;6:259-66.
30. Ng IO, Lai EC, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992;70:45-9.
31. Kemeny F, Vadrot J, Wu A, et al. Morphological and histological features of resected hepatocellular carcinoma in cirrhotic patients in the West. Hepatology 1989;9:253-7.
32. lkai I, Yamaoka Y, Yamamoto Y, et al. Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metatasis: proposal as a standard therapy. Ann Surg 1998;227:433-9.
33. Izumi R, Shimizu K, Ii T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994;106:720-7.
34. Hemming AW, Cattral MS, Reed AI, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-9.
35. Nigam A, Zhurak M, Boitnott JR, et al. Factors affecting survival in Western patients following curative resection for hepatocellular carcinoma [abstract]. Gastroenterology 1995;108:A1235.
36. Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995;169:28-34.
37. Adachi E, Maeda T, Kajiyama K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 1996;77:2022-31.
38. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000;127:603-8.
39. Esnoala NF, Lauwers GY, Mirza NQ, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002;5:251-9.
40. Uenishi T, Hirohashi K, Shuto T, et al. The clinical significance of lymph node metastasis in patients undergoing surgery for hepatocellular carcinoma. Surg Today 2000;30:892-5.
41. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathological features and results of surgical treatment. Ann Surg 1990;211:277-87.
42. Watanabe J, Nakashima O, Kojiro M. Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases. Jpn J Clin Oncol 1994;24:37-41.
43. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000;191:389-94.
44. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
45. Belghiti J, Panis Y, Farges O, et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-7.
46. Chen M-F, Hwang T-L, Jeng L-B, et al. Postoperative reccurence of hepatocellular carcinoma: two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994;129:738-42.
47. Adachi E, Maeda T, Matsuma T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995;108:768-75.
48. Ko S, Nakajima Y, Kanehiro H, et al. Significant influence of accompanying chronic hepatitis status on recurrency of hepatocellular carcinoma after hepatectomy: result of multivariate analysis. Ann Surg 1996;224:591-5.
49. Shirabe K, Takenaka K, Taketomi A, et al. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996;77:1050-5.
50. Chiu JH, Wu LH, Kao HL, et al. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma. Hepatology 1993;18:96-102.
51. Ueno S, Tanabe G, Yoshida A, et al. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis. Cancer 1999;86:248-54.
52. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995;122:1027-33.
53. Miyagawa S, Kawasaki S, Makuuchi M, et al. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996;24:307-10.
54. Tanabe G, Nuruki K, Baba Y, et al. A comparison of hepatocellular carcinoma associated with HBV or HCV infection. Hepatogastroenterology 1999;46:2442-6.
55. Wu CC, Tang JS, Lin MC, et al. Comparison of liver resection for hepatocellular carcinoma in hepatitis B and hepatitis C-related cirrhotic patients. Hepatogastroenterology 1999;46:651-5.
56. Ikeda K, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25.
57. Yamanaka N, Tanaka T, Tanaka W, et al. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 1997;79:1509-15.
58. Marcos M, Dubois S, Bralet MP, et al. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum. Am J Clin Pathol 2001;116:738-43.
59. Vauthey JN, Walsh G, Vlastos G, Lauwers G. Importance of field cancerisation in clinical oncology. Lancet Oncol 2000;1:15-6.
60. Nishiguchi S, Kuroki T, Nakatani S, et al. Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-5.